HK1197194A1 - Left ventricular diastolic function improving agent - Google Patents
Left ventricular diastolic function improving agentInfo
- Publication number
- HK1197194A1 HK1197194A1 HK14110827.2A HK14110827A HK1197194A1 HK 1197194 A1 HK1197194 A1 HK 1197194A1 HK 14110827 A HK14110827 A HK 14110827A HK 1197194 A1 HK1197194 A1 HK 1197194A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- left ventricular
- improving agent
- function improving
- diastolic function
- ventricular diastolic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011169389 | 2011-08-02 | ||
| PCT/JP2012/069609 WO2013018837A1 (ja) | 2011-08-02 | 2012-08-01 | 左室拡張機能改善剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1197194A1 true HK1197194A1 (en) | 2015-01-09 |
Family
ID=47629356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK14110827.2A HK1197194A1 (en) | 2011-08-02 | 2014-10-29 | Left ventricular diastolic function improving agent |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9682065B2 (de) |
| EP (1) | EP2740475A4 (de) |
| JP (1) | JP6052175B2 (de) |
| KR (1) | KR20140056250A (de) |
| CN (1) | CN103717219B (de) |
| AU (1) | AU2012290987B2 (de) |
| BR (1) | BR112014002377A2 (de) |
| CA (1) | CA2842906A1 (de) |
| HK (1) | HK1197194A1 (de) |
| IL (1) | IL230686A0 (de) |
| MX (1) | MX2014000971A (de) |
| RU (1) | RU2627842C2 (de) |
| SG (1) | SG2014007603A (de) |
| TW (1) | TW201321003A (de) |
| WO (1) | WO2013018837A1 (de) |
| ZA (1) | ZA201401487B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106748951B (zh) | 2012-07-19 | 2020-07-24 | 开曼化学股份有限公司 | 作为在治疗ep4介导的疾病和病状中使用的ep4受体选择性激动剂的二氟内酰胺化合物 |
| US9676712B2 (en) | 2013-03-15 | 2017-06-13 | Cayman Chemical Company, Inc. | Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions |
| SG11201507470WA (en) | 2013-03-15 | 2015-10-29 | Cayman Chemical Co Inc | Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions |
| JP6281735B2 (ja) * | 2013-03-19 | 2018-02-21 | トーアエイヨー株式会社 | 急性心不全治療薬の評価方法、及び、急性心不全モデルの作製方法 |
| AU2014290512A1 (en) | 2013-07-19 | 2015-11-12 | Cayman Chemical Company, Inc. | Methods, systems, and compositions for promoting bone growth |
| CN115154619A (zh) * | 2016-02-04 | 2022-10-11 | 西泽普研究与发展有限责任公司 | 受控释放和层状的环糊精包合物媒介物 |
| ES2954717T3 (es) * | 2017-05-22 | 2023-11-23 | Ono Pharmaceutical Co | Antagonista de EP4 |
| RU2762989C1 (ru) * | 2020-09-28 | 2021-12-24 | федеральное государственное автономное образовательное учреждение высшего образования "Российский университет дружбы народов" (РУДН) | Способ лечения собак, больных дилатационной кардиомиопатией, осложненной застойной сердечной недостаточностью |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS503362B1 (de) | 1970-06-10 | 1975-02-04 | ||
| JPS5231404B1 (de) | 1971-04-28 | 1977-08-15 | ||
| JPS57156460A (en) | 1981-03-20 | 1982-09-27 | Ono Pharmaceut Co Ltd | Stabilized composition of prostaglandin and prostaglandin mimic compound, and its preparation |
| US5938890A (en) | 1998-06-27 | 1999-08-17 | Automatic Manufacturing Systems, Inc. | Adhesive components peel and apply apparatus and method |
| OA12117A (en) | 1999-12-22 | 2006-05-04 | Pfizer Prod Inc | EP4 receptor selective agonists in the treatment of osteoporosis. |
| ATE327751T1 (de) * | 2000-01-31 | 2006-06-15 | Pfizer Prod Inc | Verwendung von aktivatoren des prostaglandinrezeptores 4 zur behandlung von akuter oder chronischer niereninsuffizienz |
| WO2002016311A1 (fr) | 2000-08-22 | 2002-02-28 | Ono Pharmaceutical Co., Ltd. | Derives d'acide carboxylique, procede de production de ceux-ci et medicaments contenant ceux-ci comme principe actif |
| BR0211201A (pt) | 2001-07-16 | 2004-07-13 | Hoffmann La Roche | Composto, processo para a preparação desse composto, sua utilização, composição farmacêutica que compreende o mesmo e método para o tratamento de uma enfermidade em um mamìfero |
| AU2002328338C1 (en) | 2001-07-16 | 2009-01-08 | Ono Pharmaceutical Co., Ltd | 2 pyrrolidone derivatives as prostanoid agonists |
| TWI313608B (en) * | 2001-07-23 | 2009-08-21 | Ono Pharmaceutical Co | Lower bone mass treating agent containing er4 agonist as active ingredient |
| EP1782830A4 (de) * | 2004-08-10 | 2009-07-29 | Ono Pharmaceutical Co | Mittel zur prävention und/oder behandlung von erkrankungen der unteren harnwege mit ep4 agonist |
| WO2006016695A1 (ja) | 2004-08-10 | 2006-02-16 | Ono Pharmaceutical Co., Ltd. | Ｅｐ４アゴニストを含有してなる高カリウム血症の予防および／または治療剤 |
| JP2006321737A (ja) | 2005-05-18 | 2006-11-30 | Ono Pharmaceut Co Ltd | Ｅｐ４アゴニストを含有する神経変性疾患の予防、治療および／または進展抑制剤 |
-
2012
- 2012-08-01 JP JP2013526948A patent/JP6052175B2/ja not_active Expired - Fee Related
- 2012-08-01 US US14/236,474 patent/US9682065B2/en not_active Expired - Fee Related
- 2012-08-01 WO PCT/JP2012/069609 patent/WO2013018837A1/ja active Application Filing
- 2012-08-01 EP EP12819579.9A patent/EP2740475A4/de not_active Withdrawn
- 2012-08-01 AU AU2012290987A patent/AU2012290987B2/en not_active Ceased
- 2012-08-01 CN CN201280038310.1A patent/CN103717219B/zh not_active Expired - Fee Related
- 2012-08-01 SG SG2014007603A patent/SG2014007603A/en unknown
- 2012-08-01 MX MX2014000971A patent/MX2014000971A/es unknown
- 2012-08-01 TW TW101127773A patent/TW201321003A/zh not_active IP Right Cessation
- 2012-08-01 BR BR112014002377A patent/BR112014002377A2/pt not_active IP Right Cessation
- 2012-08-01 KR KR1020147002583A patent/KR20140056250A/ko not_active Application Discontinuation
- 2012-08-01 CA CA2842906A patent/CA2842906A1/en not_active Abandoned
- 2012-08-01 RU RU2014107904A patent/RU2627842C2/ru not_active IP Right Cessation
-
2014
- 2014-01-28 IL IL230686A patent/IL230686A0/en unknown
- 2014-02-26 ZA ZA2014/01487A patent/ZA201401487B/en unknown
- 2014-10-29 HK HK14110827.2A patent/HK1197194A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ620451A (en) | 2015-11-27 |
| SG2014007603A (en) | 2014-03-28 |
| BR112014002377A2 (pt) | 2017-02-21 |
| CN103717219B (zh) | 2017-02-15 |
| JPWO2013018837A1 (ja) | 2015-03-05 |
| RU2014107904A (ru) | 2015-09-10 |
| CA2842906A1 (en) | 2013-02-07 |
| EP2740475A4 (de) | 2015-02-25 |
| TWI562778B (de) | 2016-12-21 |
| ZA201401487B (en) | 2015-12-23 |
| RU2627842C2 (ru) | 2017-08-14 |
| US20140179606A1 (en) | 2014-06-26 |
| JP6052175B2 (ja) | 2016-12-27 |
| KR20140056250A (ko) | 2014-05-09 |
| IL230686A0 (en) | 2014-03-31 |
| CN103717219A (zh) | 2014-04-09 |
| MX2014000971A (es) | 2014-02-27 |
| TW201321003A (zh) | 2013-06-01 |
| AU2012290987A1 (en) | 2014-02-20 |
| US9682065B2 (en) | 2017-06-20 |
| EP2740475A1 (de) | 2014-06-11 |
| WO2013018837A1 (ja) | 2013-02-07 |
| AU2012290987B2 (en) | 2017-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1199193A1 (en) | Heart occlusion devices | |
| HK1198893A1 (en) | Heart occlusion devices | |
| EP2890418A4 (de) | Ventrikuläre manschette | |
| ZA201305801B (en) | Heart valve | |
| EP2647707A4 (de) | Therapeutikum mit zytotoxizitätsanzeige | |
| PL2510864T3 (pl) | Zmywarka do naczyń | |
| ZA201403090B (en) | Tropicalizing agent | |
| GB201114212D0 (en) | Therapeutic agents | |
| PL2522268T3 (pl) | Zmywarka do naczyń | |
| PL2609894T3 (pl) | Zastawka serca | |
| HK1197194A1 (en) | Left ventricular diastolic function improving agent | |
| EP2928536A4 (de) | Ventrikulärer tavr-katheter | |
| GB201119401D0 (en) | Therapeutic agents | |
| PL2543305T3 (pl) | Zmywarka do naczyń | |
| EP2777736A4 (de) | Absaugkatheter | |
| PL2583613T3 (pl) | Zmywarka do naczyń | |
| EP2796096A4 (de) | Medizinischer port | |
| EP2674157A4 (de) | Therapeutisches mittel für diastolisches kongestives herzversagen | |
| IL232239A0 (en) | Medical use | |
| EP2787050A4 (de) | Lecithin-organogel-bildner | |
| EP2767208A4 (de) | Geschirrspüler | |
| GB2497286B (en) | Catheter | |
| PL2683284T3 (pl) | Zmywarka do naczyń | |
| GB201114901D0 (en) | Vascular treatments | |
| TWI562734B (en) | Sense-improving agent |